Chronic Pain Clinical Trial
Official title:
Integrating Mind-Body Practices Into Primary Care Treatment: The IMPaCT Pilot Study
The current study is a pilot RCT of a CIH stepped approach to care.
Status | Not yet recruiting |
Enrollment | 60 |
Est. completion date | February 29, 2028 |
Est. primary completion date | April 30, 2027 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria 1. 18 years or older 2. English-speaking 3. Have a recent University of Washington system visit (within 6 months of data pull). At that index visit the potential patient participant must have a diagnosis indicating the presence of pain and at least one prior visit with diagnosis indicating the presence of pain at least three months apart (using International Classification of Diseases [ICD] codes). This timeframe will ensure that the patient meets the standard criteria for a chronic pain designation. Pain will include back pain, neck pain, limb/extremity pain, joint pain, arthritic disorders (except gout and neuropathic arthropathy), fibromyalgia, headache, orofacial, ear, and temporomandibular disorder, musculoskeletal chest pain, and/or other pain. 4. At least a 4 on the pain intensity (P), interference with enjoyment of life (E), and interference with general activity (G; PEG) at the time of study screening. 5. Posttraumatic stress disorder (PTSD) diagnosis at any 2021-2023 visit (using ICD codes) and/or screen positive for significant PTSD symptoms (=31 on the PTSD Checklist-5 [PCL-5]) with a Criterion A event and/or destabilizing life event. Difficulty in recruitment may result in contingency plans, including reducing the PCL-5 cutoff score to 28, using subthreshold "Majority" ("Meeting three of the four DSM-5 criterion categories") and/or a "Five symptom" designation ("Meeting at least one symptom in each criterion [i.e., at least one B, C, D, and E symptom], but not meet fully-threshold PTSD") definitions. Exclusion Criteria 1. Current suicidal ideation and intent identified at the time of study screening/informed consent. 2. Severe cognitive impairment preventing individual from participating |
Country | Name | City | State |
---|---|---|---|
United States | University of Washington | Seattle | Washington |
Lead Sponsor | Collaborator |
---|---|
University of Washington | National Center for Complementary and Integrative Health (NCCIH) |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Barriers/facilitators of success | Qualitative check-ins related to barriers/facilitators of success | Baseline, 3-months, 6-months, 9-months | |
Other | Feasibility of Intervention Measure | Feasibility of Intervention; 1-5; higher scores indicate better outcome | 6-months | |
Other | Acceptability of Intervention Measure | Acceptability of Intervention; 1-5; higher scores indicate better outcome | 6-months | |
Other | Appropriateness of Intervention Measure | Appropriateness of Intervention; 1-5; higher scores indicate better outcome | 6-months | |
Other | Costs of Intervention delivery/services used | Costs of Intervention delivery/services used | 6-months | |
Primary | Patient Reported Outcome Measurement System - Pain Interference | Pain interference; 0-100; higher scores indicate worse outcome | Baseline, 3-months, 6-months, 9-months | |
Primary | Clinician-administered posttraumatic stress disorder scale | PTSD symptoms; 0-80; higher scores indicate worse outcome | Baseline, 3-months, 6-months, 9-months | |
Secondary | pain intensity (P), interference with enjoyment of life (E), and interference with general activity (G) | Pain severity and interference; 0-10; higher scores indicate worse outcome | Screening, measurement-based care (assessed every 2-weeks until study completion), Baseline, 3-months, 6-months, 9-months | |
Secondary | Posttraumatic stress disorder checklist for DSM-5 | PTSD Symptoms; 0-80; higher scores indicate worse outcome | Screening, measurement-based care (assessed every 2-weeks until study completion) | |
Secondary | Item 1 from Flourishing Measure | Emotional well-being; 0-10; higher scores indicate better outcome | Measurement-based care (assessed every 2-weeks until study completion), Baseline, 3-months, 6-months, 9-months | |
Secondary | Five Facet Mindfulness Questionnaire | Mindfulness; 1-5; higher scores indicate better outcome | Baseline, 3-months, 6-months, 9-months | |
Secondary | Patient Health Questionnaire - Item 9 | Suicidal ideation; 0-3; higher scores indicate worse outcome | Screening, Baseline, 3-months, 6-months, 9-months | |
Secondary | Short Form-12 - Physical Health | Physical health functioning; 0-12; higher scores indicate better outcome | Baseline, 3-months, 6-months, 9-months | |
Secondary | Short Form-12 - Mental Health | Mental health functioning; 0-12; higher scores indicate better outcome | Baseline, 3-months, 6-months, 9-months | |
Secondary | Meaning in Life Questionnaire | Meaning in life; 1-7; higher scores indicate better outcome | Baseline, 3-months, 6-months, 9-months |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT01659073 -
Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation
|
N/A | |
Recruiting |
NCT05914311 -
Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration
|
N/A | |
Recruiting |
NCT05422456 -
The Turkish Version of Functional Disability Inventory
|
||
Enrolling by invitation |
NCT05422443 -
The Turkish Version of Pain Coping Questionnaire
|
||
Completed |
NCT05057988 -
Virtual Empowered Relief for Chronic Pain
|
N/A | |
Completed |
NCT04385030 -
Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury
|
N/A | |
Recruiting |
NCT06206252 -
Can Medical Cannabis Affect Opioid Use?
|
||
Completed |
NCT05103319 -
Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
|
||
Completed |
NCT03687762 -
Back on Track to Healthy Living Study
|
N/A | |
Completed |
NCT04171336 -
Animal-assisted Therapy for Children and Adolescents With Chronic Pain
|
N/A | |
Completed |
NCT03179475 -
Targin® for Chronic Pain Management in Patients With Spinal Cord Injury
|
Phase 4 | |
Completed |
NCT03418129 -
Neuromodulatory Treatments for Pain Management in TBI
|
N/A | |
Completed |
NCT03268551 -
MEMO-Medical Marijuana and Opioids Study
|
||
Recruiting |
NCT06060028 -
The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain
|
N/A | |
Recruiting |
NCT06204627 -
TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain
|
N/A | |
Completed |
NCT05496205 -
A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers
|
Phase 1 | |
Completed |
NCT00983385 -
Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics
|
Phase 3 | |
Recruiting |
NCT05118204 -
Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization
|
Phase 4 | |
Terminated |
NCT03538444 -
Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder
|
N/A | |
Not yet recruiting |
NCT05812703 -
Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain
|